Literature DB >> 11687964

Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.

P Tarapore1, Y Tokuyama, H F Horn, K Fukasawa.   

Abstract

The p53 tumor suppressor protein regulates centrosome duplication through multiple pathways, and p21(Waf1/Cip1) (Waf1), a major target of p53's transactivation function, has been shown to be one of the effectors. However, it had been unclear whether the p53's Waf1-independent centrosome duplication regulatory pathways require its transactivation function. In human cancers, specific residues of p53 are mutated at a high frequency. These 'hot spot' mutations abrogate p53's transactivation function. If p53 regulates centrosome duplication in a transactivation-independent manner, different 'hot spot' mutants may regulate centrosome duplication differently. To test this, we examined the effect of two 'hot spot' mutants (R175H and R249S) for their centrosome duplication regulatory activities. We found that R175H lost the ability to regulate centrosome duplication, while R249S partially retained it. Moreover, R249S associates with both unduplicated and duplicated centrosomes similar to wild-type p53, while R175H only associates with duplicated, but not unduplicated centrosomes. Since cyclin-dependent kinase 2 (CDK2) triggers initiation of centrosome duplication, and p53 is phosphorylated on Ser 315 by CDK2, we examined the p53 mutants with a replacement of Ser 315 to Ala (A) and Asp (D), both of which retain the transactivation function. We found that S315D retained a complete centrosome duplication activity, while S315A only partially retained it. Moreover, S315D associates with both unduplicated and duplicated centrosomes, while S315A associates with only duplicated, but not unduplicated centrosomes. Thus, p53 controls the centrosome duplication cycle both in transactivation-dependent and transactivation-independent manners, and the ability to bind to unduplicated centrosomes, which is controlled by phosphorylation on Ser 315, may be important for the overall p53-mediated regulation of centrosome duplication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687964     DOI: 10.1038/sj.onc.1204848

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.

Authors:  Shih-Shun Chen; Pi-Chu Chang; Yu-Wen Cheng; Fen-Mei Tang; Young-Sun Lin
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

Review 2.  Links between mutant p53 and genomic instability.

Authors:  Walter Hanel; Ute M Moll
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

3.  The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis.

Authors:  Roland P Piekorz; Angelika Hoffmeyer; Christopher D Duntsch; Catriona McKay; Hideaki Nakajima; Veronika Sexl; Linda Snyder; Jerold Rehg; James N Ihle
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

4.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

Review 5.  Centrosome amplification and the origin of chromosomal instability in breast cancer.

Authors:  Jeffrey L Salisbury; Antonino B D'Assoro; Wilma L Lingle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

6.  Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl)ation in regulation of centrosome function.

Authors:  Masayuki Kanai; Wei-Min Tong; Eiji Sugihara; Zhao-Qi Wang; Kenji Fukasawa; Masanao Miwa
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  TopBP1 localises to centrosomes in mitosis and to chromosome cores in meiosis.

Authors:  Kaarina Reini; Lahja Uitto; David Perera; Peter B Moens; Raimundo Freire; Juhani E Syväoja
Journal:  Chromosoma       Date:  2004-05-06       Impact factor: 4.316

8.  Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells.

Authors:  Christiane D Fichter; Corinna Herz; Claudia Münch; Oliver G Opitz; Martin Werner; Silke Lassmann
Journal:  BMC Cell Biol       Date:  2011-04-06       Impact factor: 4.241

9.  The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers.

Authors:  Michelle T Paulsen; Adrienne M Starks; Frederick A Derheimer; Sheela Hanasoge; Liwu Li; Jack E Dixon; Mats Ljungman
Journal:  Mol Cancer       Date:  2006-06-19       Impact factor: 27.401

10.  Centrosome aberrations associated with cellular senescence and p53 localization at supernumerary centrosomes.

Authors:  Susumu Ohshima
Journal:  Oxid Med Cell Longev       Date:  2012-10-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.